Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: Comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography

Journal of Computer Assisted Tomography

Volumn 31, Issue 3, 2007, Pages 342-347

  Hur, Jin ^a   Yoon, Choon Sik ^a,b   Ryu, Young Hoon ^a   Yun, Mi Jin ^a   Suh, Jin Suck ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Fluorodeoxyglucose positron emission tomography (FDG PET); Magnetic resonance imaging (MRI); Multi detector computed tomography (MDCT); Multiple myeloma; Spine

Indexed keywords

BONE; ELECTRONS; MAGNETISM; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; POSITRONS; RESONANCE;

BONE MARROW; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY; LESION ANALYSIS; MAGNETIC RESONANCE IMAGING; MULTI-DETECTOR COMPUTED TOMOGRAPHY; MULTIDETECTOR ROW COMPUTED TOMOGRAPHY; MULTIPLE MYELOMA; SPINE; STAGE III;

MAGNETIC RESONANCE IMAGING;

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BONE LESION; BONE MARROW DISEASE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR LOCALIZATION; VERTEBRA;

EID: 34249780345     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000237820.41549.c9     Document Type: Article

References (17)

1. Bartl R, Frisch B, Diem H, et al. Histologic, biochemical, and clinical parameters for monitoring multiple myeloma. Cancer. 1991; 68: 2241-2250.
2. Rahmoui A, Divine M, Mathieu D, et al. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging. AJR Am J Roentgenol. 1993;160:1049-1052.
3. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36:842-854.
4. Durie BG, Kyle RA, Belch A, et al. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J. 2003;4:379-398.
5. Barlogie B, Shaughnessy J, Tricot G, et al. Treatment of multiple myeloma. Blood. 2004;103:20-32.
6. Schreiman JS, McLeod RA, Kyle RA, et al. Multiple myeloma: evaluation by CT. Radiology. 1985;154:483-486.
7. Solomon A, Rahamani R, Seligsohn U, et al. Multiple myeloma: early vertebral involvement assessed by computerised tomography. Skeletal Radiol. 1984;11:258-261.
8. Laroche M, Assoun J, Sixou L, et al. Comparison of MRI and computed tomography in the various stages of plasma cell disorders: correlations with biological and histological findings. Clin Exp Rheumatol. 1996;14:171-176.
9. Mahnken AH, Wildberger JE, Gehbauer G, et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol. 2002;178:1429-1436.
10. Angtuaco EJ, Fassas AB, Walker R, et al. Multiple myeloma: clinical review and diagnostic imaging. Radiology. 2004;231:11-23.
11. Horger M, Claussen CD, Bross-Bach U, et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol. 2005;54:289-297.
12. Schirrmeister H, Bommer M, Buck AK, et al. Initial results in the assessment of multiple myeloma using F-18 FDG PET. Eur J Nucl Med Mol Imaging. 2002;29:361-366.
13. Jadvar H, Conti PS. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol. 2002;31:690-694.
14. Bredella MA, Steinbach L, Caputo G, et al. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005;184:1199-1204.
15. Durie BG, Waxman AD, D'Agnolo A, et al. Whole body 18F-FDG-PET identifies high-risk myeloma. J Nucl Med. 2002;43:1457-1463.
16. Nanni C, Zamagni E, Farsad M, et al. Role of 18F-FDG-PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Eur J Nucl Med Mol Imaging. 2006;33:525-531.
17. Breyer RJ 3rd, Mulligan ME, Smith SE, et al. Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma. Skeletal Radiol. 2006;35:632-640.